Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality - Top-Institutions - MDSpire

Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality

  • By

  • Fabio Bioletto

  • Alessia Pusterla

  • Federica Fraire

  • Lorenzo Sauro

  • Michela Presti

  • Emanuela Arvat

  • Ezio Ghigo

  • Massimo Procopio

  • Marco Barale

  • August 28, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Clinical Research

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Bone Biology
    • Pharmacology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Osteoporosis Research
    • Epidemiology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Clinical Epidemiology

Original Source(s)

Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality

  • by Fabio Bioletto, Alessia Pusterla, Federica Fraire, Lorenzo Sauro, Michela Presti, Emanuela Arvat, Ezio Ghigo, Massimo Procopio, Marco Barale

  • August 28, 2024

Related Content

A Nomogram for Predicting Low Bone Mineral Density in the Elderly Using Chest CT

Gut microbiota orchestrates bone homeostasis: a multi-pathway network from intestine to skeleton

Correction: Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry study